Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Presented for research literature review only Sorokin P (2011)
Pharmacy: PerfectRx, which carries active Iowa Board exposure, and ProRx, which has exited tirzepatide
Different payers have different cost-effectiveness thresholds, and for academic publishing, the commonly used cost-effectiveness ratio is $100,000 per QALY, but different payers may have different thresholds, corresponding author Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Womens Hospital, said in an interview with The American Journal of Managed Care
Your provider uses your genetic insightsalong with your clinical responseto determine if your dose needs to increase over time
Remember that reconstituted peptide should be used within 28 days
